Consistently tracking KL-6 levels may help predict acute exacerbations in IPF and other types of fibrotic ILDs, a study ...

How do you want to be remembered after your passing? Columnist Sam Kirton shares the steps he's taking to leave a positive legacy.

GRI-0621 appears to reduce markers of fibrosis in people with idiopathic pulmonary fibrosis, interim clinical trial data ...

Columnist Sam Kirton finds that filling the silence is part of living with a chronic condition, especially amid retirement and COVID-19.

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic pulmonary fibrosis.

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic ...

A study found 10 IPF patients given EGCG, a green tea antioxidant, for 14 days had normal levels of pro-fibrotic proteins in lung tissue.

The U.S. Food and Drug Administration has granted Bristol Myers Squibb’s investigational therapy BMS-986278 breakthrough therapy status.

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.